NCT01939431

Brief Summary

Background: \- Podoconiosis is a disease of the lymph vessels in the legs and feet. It is caused by long-term barefoot exposure to irritant soils, such as those in volcanic areas. It causes severe swelling and disfigurement, as well as infection and chronic pain. It mostly affects people who live in tropical Africa, Central and South America, and India. The reasons why some people develop this disease and others do not is not well understood. Researchers want to study people with the disease and healthy volunteers in Ethiopia. They will collect skin and blood samples to study genetic and other aspects of the disease. Objectives: \- To collect skin and blood samples to study genetic and other aspects of podoconiosis. Eligibility:

  • Individuals at least 18 years of age who have podoconiosis (early stage or advanced stage).
  • Healthy volunteers at least 18 years of age.
  • Participants will be recruited from a study clinic and hospital in Ethiopia. Design:
  • Participants will be screened with a physical exam and medical history.
  • Blood samples will be collected. A skin biopsy will be performed to collect tissue for study. People who have podoconiosis will provide affected and unaffected tissue. Healthy volunteers will provide a single skin biopsy sample.
  • Treatment will not be provided as part of this study.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 20, 2013

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

September 5, 2013

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 11, 2013

Completed
6.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2019

Completed
Last Updated

January 14, 2021

Status Verified

January 1, 2021

Enrollment Period

6.4 years

First QC Date

September 5, 2013

Last Update Submit

January 13, 2021

Conditions

Keywords

PodoconiosisEthiopian

Outcome Measures

Primary Outcomes (1)

  • Natural History

    To study genetic and other aspects of podoconiosis using data from skin and blood samples.

    Ongoing

Study Arms (3)

Advanced

advanced stage podoconiosis

Control

non-podoconiosis controls

Early

early stage podoconiosis

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with podoconiosis@@@@@@

You may qualify if:

  • All individuals included in our study will be adults (greater than or equal to 18 years) because the average age of onset of the disease is during the third decade of life. In addition, in Ethiopia the legal age to give independent consent for research is 18 years or older. Previous studies have shown that diagnosis of podoconiosis using physical diagnostic criteria in endemic highland areas is highly accurate. To rule out filarial elephantiasis, a rapid ICT card test will be done. Advanced stage podoconiosis cases will be included in the study based on prior assessment of an experienced surgeon (Dr Wendemagegn Enbiale Yeshanehe) who assures eligibility for nodulectomy if a patient with clinical stage III, IV or V podoconiosis has fibrotic nodules. Early clinical stage podoconiosis patients will be individuals with negative filarial test and at clinical stages I or II. Controls will be individuals with no past or current history, signs and symptoms of podoconiosis and no family history of podoconiosis.

You may not qualify if:

  • In addition to clinical criteria that make patients and controls non-eligible to undergo surgery, we will also exclude individuals with skin infection, skin lesion at the prospective biopsy site, medical contradictions to biopsy, history of adenolymphangitis during the previous 2 weeks, topical steroid treatment during the previous 2 weeks, with biologically related family members that are included in the study, recent infection, use of systemic antibiotics and use of systemic steroids. Attempts will be made to enroll an equal number of men and women. No prisoners, pregnant women or fetuses will be included in this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bahir Dar University, Medical and Healath Science College

Bahir Dar, Ethiopia

Location

Related Publications (3)

  • Bullard JH, Purdom E, Hansen KD, Dudoit S. Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments. BMC Bioinformatics. 2010 Feb 18;11:94. doi: 10.1186/1471-2105-11-94.

    PMID: 20167110BACKGROUND
  • Cheng WC, Shu WY, Li CY, Tsai ML, Chang CW, Chen CR, Cheng HT, Wang TH, Hsu IC. Intra- and inter-individual variance of gene expression in clinical studies. PLoS One. 2012;7(6):e38650. doi: 10.1371/journal.pone.0038650. Epub 2012 Jun 18.

    PMID: 22723873BACKGROUND
  • Davey G, Gebrehanna E, Adeyemo A, Rotimi C, Newport M, Desta K. Podoconiosis: a tropical model for gene-environment interactions? Trans R Soc Trop Med Hyg. 2007 Jan;101(1):91-6. doi: 10.1016/j.trstmh.2006.05.002. Epub 2006 Aug 1.

    PMID: 16884751BACKGROUND

MeSH Terms

Conditions

Elephantiasis

Condition Hierarchy (Ancestors)

LymphedemaLymphatic DiseasesHemic and Lymphatic Diseases

Study Officials

  • Charles N Rotimi, M.D.

    National Human Genome Research Institute (NHGRI)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
NIH
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 5, 2013

First Posted

September 11, 2013

Study Start

August 20, 2013

Primary Completion

December 30, 2019

Study Completion

December 30, 2019

Last Updated

January 14, 2021

Record last verified: 2021-01

Locations